← back to search

Arnoud Boot

GenomeScan (Netherlands) · NL
Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research interests include Genetic factors in colorectal cancer, Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, and RNA modifications and cancer.
h-index
36
citations
21,962
works
146
NIH funding
primary concept
Biology
email

Recent publications

Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers
Proceedings of the National Academy of Sciences 2022cited by 51position: firstdoi
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.
2022cited by 25position: contributordoi
Accuracy of mutational signature software on correlated signatures.
2022cited by 8position: contributordoi
mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery
2022cited by 1position: contributordoi
The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
2021cited by 37position: contributordoi
Mutational processes in cancer preferentially affect binding of particular transcription factors.
2021cited by 9position: contributordoi
The repertoire of mutational signatures in human cancer
Nature 2020cited by 3,686position: middledoi
The repertoire of mutational signatures in human cancer.
2020cited by 2,860position: contributordoi
Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma
Journal of Clinical Investigation 2020cited by 105position: middledoi
Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma
Journal of Clinical Investigation 2020cited by 101position: contributordoi
The mutational landscape of early‐ and typical‐onset oral tongue squamous cell carcinoma
Cancer 2020cited by 52position: middledoi
Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types.
2020cited by 51position: contributordoi
Recurrent APC Splice Variant c.835-8A>G in Patients With Unexplained Colorectal Polyposis Fulfilling the Colibactin Mutational Signature
Gastroenterology 2020cited by 38position: middledoi
A tumor-associated splice-isoform of <i>MAP2K7</i> drives dedifferentiation in MBNL1-low cancers via JNK activation.
2020cited by 35position: contributordoi
Recurrent APC Splice Variant c.835-8A>G in Patients With Unexplained Colorectal Polyposis Fulfilling the Colibactin Mutational Signature.
2020cited by 29position: contributordoi
Monoallelic NTHL1 Loss-of-Function Variants and Risk of Polyposis and Colorectal Cancer.
2020cited by 26position: contributordoi
Multiple neoplasia in a patient with Gitelman syndrome harboring germline monoallelic &lt;i&gt;MUTYH&lt;/i&gt; mutation.
2020cited by 4position: contributordoi
Recurrent mutations in topoisomerase 2a cause a novel mutator phenotype in human cancers
2020cited by 0position: contributordoi
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
Cancer Cell 2019cited by 297position: middledoi
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.
2019cited by 228position: contributordoi
Allelic Switching of <i>DLX5</i>, <i>GRB10</i>, and <i>SVOPL</i> during Colorectal Cancer Tumorigenesis.
2019cited by 9position: contributordoi
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Cancer Discovery 2017cited by 977position: middledoi
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Science Translational Medicine 2017cited by 375position: middledoi
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
˜The œLancet. Gastroenterology & hepatology 2016cited by 308position: middledoi
Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer
Scientific Reports 2015cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2019–2022)Alvin Wei Tian Ng · Cancer Research UK Cambridge Center4 papers (2017–2022)Tom Van Wezel · Consorci Institut D'Investigacions Biomediques August Pi I Sunyer4 papers (2019–2022)Steven G. Rozen · National Cancer Centre Singapore4 papers (2020–2022)Steve Rozen · Chang Gung University3 papers (2017–2022)Willie Yu · Duke-NUS Medical School3 papers (2017–2022)Choon Kiat Ong · Cellular Research (United States)2 papers (2019–2020)Jason Yongsheng Chan · Duke-NUS Medical School2 papers (2020–2020)Bin Tean Teh · SingHealth Duke-NUS Academic Medical Centre2 papers (2017–2020)Christophe Rosty · The University of Queensland1 papers (2020–2020)Nishant Agrawal · Institute of Chartered Financial Analysts of India1 papers (2020–2020)Viraj Shah · University of Illinois Chicago1 papers (2022–2022) · 1 papers (2020–2020)Maartje Nielsen · University of Kentucky1 papers (2020–2020) · 1 papers (2022–2022)Noel F.C.C. de Miranda · Leiden University1 papers (2020–2020)Jeffrey N. Myers · The University of Texas MD Anderson Cancer Center1 papers (2020–2020)Curtis R. Pickering · The University of Texas MD Anderson Cancer Center1 papers (2020–2020)Daniel L. Faden · Broad Institute1 papers (2020–2020)Karin C. Nitiss · University of Illinois Chicago1 papers (2022–2022)